Helixate FS: No Longer Manufactured Feb 12, 2019Feb 10, 2019 Brand: Helixate FS (antihemophilic factor), Intravenous Infusion Parent Company: CSL Behring Drug Type: Prescription Drug Category: Hematology Campaign: Post-Launch Targeting: HCPs, Patients, Caregivers Patient Website: HCP Website: https://www.helixatefs.com/ No longer manufactured Afstyla is next-generation treatment option